Macquarie Group provides outlook update for FY19

Macquarie

Macquarie Group has delivered strong return on equity of 16.8% for the financial year ended 30 June 2018, which is 15.2% more than previous year returns. This comes after, profit attributable to shareholders grew $2,557 million from $2,217 million in FY17. The increase in profit is underpinned by a strong risk management framework and capital position. Group’s earnings have grown by 25% over the past 5 years delivering consistent dividend growth of 21% over five years CAGR.

International income contributes 67% of total income $10,920 million under which Australia region has made the highest contribution of $3,517 million. APRA Basel III Group capital at Jun 18 of $A18.8 billion, Group capital surplus of $A3.4 billion.

In short-term outlook update Group’s results for fiscal 2019 is expected to be broadly in line with FY18 which includes strong performance fees in MAM in first half of FY2019. However, the impact of foreign exchange, sale of Quadrant Energy, market conditions and other potential factors may substantially cast considerable changes in the actual results. 

MQG continues to build on portfolio mix to have advantages over diversity in business. Macquarie Asset Management, Corporate and Asset Finance and Banking and Financial Services provides annuity-style income, delivering superior returns following years of investment and acquisitions. Commodities and Global Markets and Macquarie Capital are well positioned to benefit from improvements in market conditions in medium-term. The company has already reported that strong trading conditions have been experienced in the first quarter of fiscal year 2019 followed by strong activity in CGM.

With a proven risk management framework and culture, the group has been experiencing the ongoing benefits of continued cost initiatives. Further, it has been proposed that minimum requirement for leverage ratio would be increased to 4% by APRA.

Following the outlook update announcement, Macquarie Group’s share price has increased by 1.011% to $123.880 on 11 September 2018 (12:36 PM AEST).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report